- clinical development
- Boston
- 18,854 followers
„We cannot buy culture, we have to build it” – Mike Jagielski, CEO
Values
- Learning
- Customer Focus
- Accountability
- Commitment
- Tenacity to Succeed
Development goals
- Be the clinical development partner of choice for global biotech
- Innovate in the direct patient engagement area
- Adapt to novel technology and development strategies
- Remain a private business enterprise to ensure long-term development
Social responsibility
- Contributing to hospices in Eastern Europe
- Supporting the orphanage in Poland
- Being environmentally conscious: office space, materials and recycling
- Caring for KCR team & supporting employees in need
#HBEN NGO
- HBEN NGO was created to understand real patient experiences
- Patient engagement allows for better communication & innovation
- Patient feedback leads to essential progress in trial design & execution
Media
Applied Clinical Trials
11 April 2024
Generative AI-Enabled/Augmented Clinical Trials: The Road Ahead
European Pharmaceutical Review
04 March 2024
Delivery systems for biologics
Pharmaphorum
18 October 2023
Elements in precision oncology
MassBio
23 September 2023
Guest Blog: Medical Writing: a key piece to the successful clinical trial puzzle
Clinical Research News
18 August 2023
Toward Optimizing Site Feasibility Assessment For Clinical Trials
The Medicine Maker
25 May 2023
The Imperfect Art of Biosimilars
MassBio
27 October 2022
Breaking down the Internet of Things: What does it mean for clinical research?
Applied Clinical Trials
23 August 2022
Patient-Centered Recruitment and Retention
MassBio
16 June 2022
Decentralized Manufacturing: A Path towards Smart Cell and Gene Therapy Manufacturing?
European Pharmaceutical Review
31 May 2022
Early phase CGT trials: key design elements correlating to distinctive biological characteristics
Clinical Research News
22 April 2022
Continuous Bioprocessing of Biologics: The Future is Bright
Clinical Research News
26 January 2022
Looking Forward to EU Regulation (EU) No 536/2014
Applied Clinical Trials
02 December 2021
Oncolytic Virus Immunotherapy: A Brief Overview and Considerations for Clinical Trial Planning
Medium
16 November 2021
DCT + Traditional Tech for Clinical Trials?
MassBio News
09 November 2021
What to Consider When Partnering with a Clinical Trial Consultancy: Tips for Biotech Companies
Applied Clinical Trials
08 October 2021
The Post-Pandemic CRO Landscape
Applied Clinical Trials
03 August 2021
Somatic Cell Therapy—Navigating the Regulatory Landscape
MassBio News
18 June 2021
Decentralized Clinical Trials: Opportunity or Challenge?
Contract Pharma
01 June 2021
The Future of Continuous Bioprocessing
Medium
25 February 2021
KCR opens new branch in Sydney, Australia
MassBio News
01 December 2020
Remote Verification of Investigational Product Management at Clinical Trial Sites
PharmaVoice
30 November 2020
2021 Year in Preview: The Year to Come and the Year That Was
The Medicine Maker
23 September 2020
The Pandemic Diaries
Regulatory Affairs Professionals Society
07 August 2020
Interacting with competent authorities during COVID-19 - A European perspective
European Pharmaceutical Review
07 July 2020
How to start up an ATMP clinical trial
MassBio News
07 July 2020
Utilizing Remote Clinical Site Monitoring During the COVID-19 Pandemic
Applied Clinical Trials
23 June 2020
Initial Design Considerations of Trials of Immuno-Oncology: Domains and Elements
Contract Pharma
20 May 2020
Pioneering Medicine Forward
Medium
12 May 2020
KCR’s Bryan Katz named in PM360’s ELITE 100
Medium
08 April 2020
New FDA Guidelines on validation of software systems: What do they mean for Quality Assurance?
Medium
08 January 2020
KCR adopts Veeva Vault Clinical Suite
PharmaVoice
27 November 2019
Creating Culture of Innovation
Medium
27 November 2019
Future digitalization of the CRO industry
Medium
07 November 2019
Immuno-Oncology Trial Implementation – Where to Start? KCR’s Webinar
Medium
09 October 2019
Consulting in the Life Sciences Industry: Making the World Small for You
Applied Clinical Trials
17 September 2019
European Regulatory Framework and General Path to Market for ATMPs
Journal of Drug Assessment
09 July 2019
Epidemiology of atopic dermatitis in Europe
Medium
09 July 2019
The Next Frontier for Regulators: Virtual & Hybrid Clinical Trials
Twitter
28 May 2019
We are so excited to welcome you to the #KCR Twitter page! We look forward to engaging with you all.
YouTube
20 September 2018
KCR Annual Development Meeting | Interviews | Part 2
Main offices
Boston office
KCR, US Inc.
30 Rowes Wharf, Suite 430
MA 02110, Boston, United States
+1 617 778 7275
Berlin office
KCR CRO GmbH
Am Kupfergraben 4-4a
10117 Berlin, Germany
+49 30 206 07 975
Warsaw office
KCR S.A.
6 Postepu str.
02-676 Warsaw, Poland
+48 22 313 13 13
If you would like to know more
feel free to...